These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 9861300)

  • 21. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
    Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans.
    Sütsch G; Bertel O; Kiowski W
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):717-25. PubMed ID: 9110115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
    Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
    Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin-1 receptor antagonism does not influence myocardial function in hypertensive dogs.
    Massart PE; Hodeige D; Van Mechelen H; Heyndrickx GR; Donckier J
    Eur J Clin Invest; 1998 Oct; 28(10):798-806. PubMed ID: 9792992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure.
    Himura Y; Liang CS; Imai N; Delehanty JM; Woolf PD; Hood WB
    J Am Coll Cardiol; 1994 Jan; 23(1):194-200. PubMed ID: 8277081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure.
    Bauersachs J; Fraccarollo D; Galuppo P; Widder J; Ertl G
    Cardiovasc Res; 2000 Jul; 47(1):142-9. PubMed ID: 10869540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats.
    Richard V; Hogie M; Thuillez C
    Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
    Udvary E; Papp JG; Végh A
    Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left stellate ganglion block has only small effects on left ventricular function in awake dogs before and after induction of heart failure.
    Müllenheim J; Preckel B; Obal D; Heiderhoff M; Hoff J; Thämer V; Schlack W
    Anesth Analg; 2000 Oct; 91(4):787-92. PubMed ID: 11004027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure.
    Ding SS; Qiu C; Hess P; Xi JF; Clozel JP; Clozel M
    Cardiovasc Res; 2002 Mar; 53(4):963-70. PubMed ID: 11922906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
    Wanecek M; Rudehill A; Hemsén A; Lundberg JM; Weitzberg E
    Crit Care Med; 1997 May; 25(5):848-57. PubMed ID: 9187606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
    Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C
    Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of nitrate accumulation in plasma during pacing-induced heart failure in conscious dogs.
    Bernstein RD; Zhang X; Zhao G; Forfia P; Tuzman J; Ochoa F; Ochoa M; Vogel T; Hintze TH
    Nitric Oxide; 1997 Oct; 1(5):386-96. PubMed ID: 9441909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The functional shift of endothelin receptor subtypes in dogs with heart failure produced by rapid ventricular pacing.
    Tadano K; Hosokawa A; Fukuroda T; Nishikibe M
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S350-3. PubMed ID: 15838318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bosentan and the endothelin system in congestive heart failure.
    Ellahham SH; Charlon V; Abassi Z; Calis KA; Choucair WK
    Clin Cardiol; 2000 Nov; 23(11):803-7. PubMed ID: 11097125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fukai D; Kinoshita M
    Cardiovasc Res; 1998 Sep; 39(3):617-24. PubMed ID: 9861304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.